Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Seliciclib to be investigated for nasopharyngeal cancer

Feb. 9, 2007

UCB and ImClone terminate CDP-791 agreement

Feb. 9, 2007

Pro-Pharmaceuticals commences NDA filing for Davanat

Feb. 8, 2007

European label extension sought for Evoltra for elderly patients with AML

Feb. 8, 2007

Romidepsin studied with bortezomib for relapsed/refractory multiple myeloma

Feb. 8, 2007

Genta to appeal Genasense non-approvable letter in CLL

Feb. 8, 2007

European orphan drug designation for Fodosine in CTCL

Feb. 8, 2007

Elacyt to be studied for metastatic colorectal cancer

Feb. 8, 2007

Glufosfamide studied in new phase II trial for recurrent, sensitive SCLC

Feb. 8, 2007

Favorable data on the gemcitabine/Myocet combination from a phase II trial

Feb. 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.